JMEEX
Price
$66.37
Change
-$0.31 (-0.46%)
Updated
Aug 15 closing price
Net Assets
5.73B
VIMSX
Price
$78.00
Change
-$0.19 (-0.24%)
Updated
Aug 15 closing price
Net Assets
196.76B
Interact to see
Advertisement

JMEEX vs VIMSX

Header iconJMEEX vs VIMSX Comparison
Open Charts JMEEX vs VIMSXBanner chart's image
JPMorgan Mid Cap Equity R5
Price$66.37
Change-$0.31 (-0.46%)
VolumeN/A
Net Assets5.73B
Vanguard Mid Cap Index Investor
Price$78.00
Change-$0.19 (-0.24%)
VolumeN/A
Net Assets196.76B
JMEEX vs VIMSX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
JMEEX vs. VIMSX commentary
Aug 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JMEEX is a StrongBuy and VIMSX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIMSX has more cash in the bank: 197B vs. JMEEX (5.73B). VIMSX pays higher dividends than JMEEX: VIMSX (1.37) vs JMEEX (0.54). JMEEX was incepted earlier than VIMSX: JMEEX (11 years) vs VIMSX (27 years). JMEEX (0.80) is less costly to investors than VIMSX (0.17). JMEEX is a more actively managed with annual turnover of: 38.00 vs. VIMSX (16.00). JMEEX has a lower initial minimum investment than VIMSX: JMEEX (0) vs VIMSX (3000). VIMSX annual gain was more profitable for investors over the last year : 14.59 vs. JMEEX (7.04). VIMSX return over 5 years is better than : 62.56 vs. JMEEX (30.13).
JMEEXVIMSXJMEEX / VIMSX
Total Expense Ratio0.700.17412%
Annual Report Gross Expense Ratio0.800.17471%
Fund Existence11 years27 years-
Gain YTD4.7118.55555%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets5.73B197B3%
Annual Yield % from dividends0.541.3740%
Returns for 1 year7.0414.5948%
Returns for 3 years19.2826.7072%
Returns for 5 years30.1362.5648%
Returns for 10 years43.32125.6434%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ROKU90.292.78
+3.18%
Roku
NNNN50.910.77
+1.54%
Anbio Biotechnology
ABOS1.420.02
+1.43%
Acumen Pharmaceuticals
KIDS19.190.06
+0.31%
OrthoPediatrics Corp
ASNS0.51-0.11
-17.94%
Actelis Networks